Your browser doesn't support javascript.
loading
Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy?
Mamtani, Anita; Grabenstetter, Anne; Sevilimedu, Varadan; Morrow, Monica; Gemignani, Mary L.
Afiliação
  • Mamtani A; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66 Street, New York, NY, 10065, USA. mamtana1@mskcc.org.
  • Grabenstetter A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Sevilimedu V; Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Morrow M; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66 Street, New York, NY, 10065, USA.
  • Gemignani ML; Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 300 East 66 Street, New York, NY, 10065, USA.
Breast Cancer Res Treat ; 197(2): 417-423, 2023 Jan.
Article em En | MEDLINE | ID: mdl-36394689
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Carcinoma Lobular / Carcinoma Ductal de Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2023 Tipo de documento: Article